GABA and mood disorders: a brief review and hypothesis

Journal of Affective Disorders

Volumn 34, Issue 4, 1995, Pages 275-281

  Petty, Frederick ^a,b  

^a VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Biological marker; Bipolar disorder; Depression; GABA; Mania; Mood disorder

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ALPRAZOLAM; ANTIDEPRESSANT AGENT; LITHIUM; MARKER; VALPROIC ACID;

4 AMINOBUTYRIC ACID BRAIN LEVEL; ARTICLE; GABAERGIC SYSTEM; HUMAN; HYPOTHESIS; MANIC DEPRESSIVE PSYCHOSIS; MOOD; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; BIPOLAR DISORDER; BRAIN STEM; DEPRESSIVE DISORDER; GAMMA-AMINOBUTYRIC ACID; HIPPOCAMPUS; HUMAN; MOOD DISORDERS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0029164246     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-0327(95)00025-I     Document Type: Article

References (59)

1. Acute ethanol ingestion raises plasma gamma aminobutyric acid levels in healthy men
2. Experimental basis for the antidepressant action of the GABA receptor agonist progabide
3. A receptors are present on noradrenergic nerve terminals in selective areas of the rat brain
4. Effifacy of divalproex vs lithium and placebo in the treatment of mania
5. A/benzodiazapine binding sites and glutamic acid decarboxylase activity in depressed suicide victims
6. Brain GABA-B binding sites in depressed suicide victims
7. Effects of major depression and ECT on plasma GABA
8. Effect of sodium valproate on mania: the GABA-hypothesis of affective disorders
9. CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls
10. CSF GABA in normal subjects and patients with depression, schizophrenia, mania, and anorexia nervosa
11. GABA levels in CSF of patients with psychiatric disorders
12. B-receptor mediated inhibition of potassium-evoked release of endogenous 5-hydroxytryptamine from mouse frontal cortex
13. Amino acid levels in depression: a preliminary investigation
14. B receptor regulation in the olfactory bulbectomized rat
15. A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic and depression: review of the literature
16. B receptors and norepinephrine-stimulated cAMP production in rat brain cortex
17. Cerebrospinal fluid γ-aminobutryric acid and homovanillic acid in depressive disorders
18. GABA(A) receptor agonists, partial agonists, and antagonists. Design and therapeutic prospects
19. Discriminative stimulus effects of melatonin in the rat
20. The potential use of GABA agonists in psychiatric disorders: evidence from studies with progabide in animal models and clinical trials
21. B binding in the frontal cortex of olfactory bulbectomized rats
22. B binding sites in rat frontal cortex: a common action of repeated administration of different classes of antidepressants and electroshock
23. Decreased GABA B receptors in helpless rats: reversal by tricyclic antidepressants
24. An overview of fengabine versus tricyclics in depression
25. B receptors are up-regulated by chronic treatment with lithium or carbamazepine. GABA hypothesis of affective disorders?
26. Therapeutic effects of fengabine, a new GABAergic agent, in depressed outpatients: a double-blind study versus clomipramine
27. Fengabine in depression: a placebo-controlled study of a GABA agonist
28. Plasma gamma-aminobutyric acid (GABA) is low in alcoholics
29. Plasma concentrations of γ-aminobutyric acid (GABA) and mood disorders: a blood test for manic depressive disease?
30. Stability of plasma gammaaminobutyric acid with time in healthy controls
31. is plasma GABA of peripheral origin?
32. Low plasma GABA is a trait-like marker for bipolar illness
33. Low plasma γ-aminobutyric acid levels in male patients with depression
34. GABA and depression
35. Does learned helplessness induction by haloperiodol involve serotonin mediation?
36. Intracortical glutamate injection produces helpless-like behavior in the rat
37. Plasma GABA in affective illness
38. GABAergic modulation of learned helplessness
39. Plasma GABA levels in psychiatric illness
40. Desipramine does not alter plasma GABA in patients with major depression
41. Cerebrospinal fluid GABA in normals and patients with affective disorders
42. Effect of acute and chronic benzodiazepines on plasma GABA in anxious patients and controls
43. Fengabine, a novel antidepressant GABAergic agent. II. Effect on cerebral noradrenergic. serotonergic and GABAergic transmission in the rat
44. The plasma concentration of GABA shows no evidence of a circadian rhythm and is stable over weeks in normal males
45. Initial human safety and tolerance study of a GABA uptake inhibitor, C1966: potential role of GABA as a mediator in the pathogenesis of schizophrenia and enemia
46. Neurochemical basis of the action of antidepressants on learned helplessness
47. Additivity of neurochemical changes in learned helplessness and imipramine
48. Antidepressant-anxiolytic interaction: decreased density of benzodiazepine receptors in rat brain following chronic administration of antidepressants
49. Parallel changes in the sensitivity of γ-aminobutyric acid and noradrenergic receptors following chronic administration of antidepressant and GABAergic drugs
50. Differential coupling of GABA-A and GABA-B receptors to the noradrenergic system
51. Alcoholism in manic depressive (bipolar) patients
52. Preliminary studies on CSF γ-aminobutyric acid levels in psychiatric patients before and during treatment with different psychotropic drugs
53. Pharmacological and therapeutic actions of GABA receptor agonists